Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap
27 juin 2024 08h00 HE
|
Annovis Bio, Inc.
MALVERN, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies...
Annovis Bio Files Patent for New Composition of Matter for Buntanetap
26 juin 2024 08h00 HE
|
Annovis Bio, Inc.
MALVERN, Pa., June 26, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies...
Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data
25 juin 2024 08h00 HE
|
Annovis Bio, Inc.
MALVERN, Pa., June 25, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies...
Annovis Bio Highlights New Alzheimer’s Data at the Alzheimer’s Association International Conference® 2024
18 juin 2024 08h00 HE
|
Annovis Bio, Inc.
MALVERN, Pa., June 18, 2024 (GLOBE NEWSWIRE) -- via IBN -- Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage drug platform company developing novel therapies for...
Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients
11 juin 2024 08h00 HE
|
Annovis Bio, Inc.
MALVERN, Pa., June 11, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage drug platform company developing novel therapies for...
Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast
05 juin 2024 08h00 HE
|
Annovis Bio, Inc.
MALVERN, Pa., June 05, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies...
Annovis Bio, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
08 oct. 2021 17h04 HE
|
Portnoy Law
Investors with losses are encouraged to contact the firm before October 18, 2021; click here to submit trade information LOS ANGELES, Oct. 08, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm...
Portnoy Law: Lawsuit Filed On Behalf of Annovis Bio, Inc. Investors
14 sept. 2021 12h08 HE
|
Portnoy Law
Click here to join the case LOS ANGELES, Sept. 14, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Annovis Bio, Inc....
Portnoy Law: Lawsuit Filed On Behalf of Annovis Bio, Inc. Investors
25 août 2021 00h09 HE
|
Portnoy Law
Click here to join the case LOS ANGELES, Aug. 25, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Annovis Bio, Inc....
Portnoy Law: Lawsuit Filed On Behalf of Annovis Bio, Inc. Investors
18 août 2021 21h28 HE
|
Portnoy Law
Click here to join the case LOS ANGELES, Aug. 18, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Annovis Bio, Inc....